| Date | Title | Description | |
|---|---|---|---|
| 10 May 2023 | On P&L | The Company releases the first quarter 2023 financial results presentation | Download |
| 10 May 2023 | On P&L | The Company releases the press release related to the first quarter 2023 financial results | Download |
| 25 Apr 2023 | On business and financial situation | ROVI commences clinical development of a new three-monthly formulation of Letrozole (Letrozole LEBE) | Download |
| 21 Feb 2023 | On business and financial situation | The Company releases the full year 2022 financial results presentation. | Download |
| 21 Feb 2023 | On business and financial situation | The Company releases the press release related to the full year 2022 financial results. | Download |
Pages
| Date | Title | Description | |
|---|---|---|---|
| 08 May 2025 | Announcement of General Shareholders’ Meeting | The Company announces the call of its 2025 Ordinary General Shareholders' Meeting | Download |
| 04 Apr 2025 | Liquidity and counterparty agreements | Liquidity contract: transactions conducted in the first quarter of 2025 | Download |
| 25 Feb 2025 | Annual Financial Reports and Audit Reports | The Company submits the 2024 Annual Financial Report | Download |
| 25 Feb 2025 | Annual Report regarding remuneration of the members of the Board of Directors | ROVI releases the 2024 annual report regarding remuneration of the members of the Board of Directors | Download |
| 07 Jan 2025 | Liquidity and counterparty agreements | Liquidity contract: transactions conducted in the fourth quarter of 2024 | Download |
Pages
| Date | Title | Description | |
|---|---|---|---|
| 30 Jul 2014 | información sobre resultados | Download | |
| 30 Jul 2014 | información sobre resultados (2) | Download | |
| 01 Jul 2014 | Información sobre dividendos | Download | |
| 12 Jun 2014 | Convocatorias y Acuerdos de Juntas y Asambleas Generales | Download | |
| 29 Apr 2014 | Información sobre resultados (2) | Download |